Huperzia phlegmaria
Huperzia phlegmaria · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Huperzia phlegmaria is a distinctive plant species primarily utilized through the preparation of its aerial parts. Scientific investigation into this species has identified several key bioactive compounds, including 5-Hydroxymethyl-2-furaldehyde, LOLIOLIDE, Lycophlegmariol A, and Phlegmariurine B. These chemical constituents are of significant interest due to their potential therapeutic applications in neurological health. Specifically, research focuses on the plant's ability to address complex conditions such as Alzheimer's Disease. Understanding these chemical profiles offers promising insights into developing future medicinal treatments.
- Synonyms
- Urostachys Simonii · Lycopodium Phlegmaria Var. Feejeense · 9 more
- Common names
- Not available
- Family
- Lycopodiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Huperzia phlegmaria is a botanical species characterized by a complex history of taxonomic classifications. Throughout various studies, it has been identified by several different names, including the synonyms Huperzia feejeensis and Huperzia simonii. Researchers have also documented the plant under the name Lepidotis phlegmaria in certain historical contexts. Furthermore, its lineage is linked to Lycopodium phlegmaria, highlighting the shifting nature of botanical nomenclature. It is even associated with Lycopodium horizontale var. submoniliforme, reflecting the intricate web of relationships within its genus.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Huperzia phlegmaria is a fascinating botanical specimen that belongs to the vast kingdom Plantae. Within this kingdom, the plant is classified under the class Equisetopsida, marking its unique evolutionary lineage. It falls specifically into the order Lycopodiales, showcasing its distinct structural characteristics. As a member of the genus Huperzia, it shares close ties with other specialized clubmosses. Ultimately, this species is a proud representative of the family Lycopodiaceae, completing its complex biological profile.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Lycopodiidae |
| Order | Lycopodiales |
| Family | Lycopodiaceae |
| Genus | Huperzia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Huperzia phlegmaria is a notable plant species with a diverse distribution spanning across the African continent. Its presence is documented throughout East Tropical Africa, specifically within the territories of Tanzania and Uganda. The species also extends its reach into South Tropical Africa, where it can be found in Malawi. Furthermore, its range reaches into West Tropical Africa, encompassing regions such as Guinea and Liberia. This wide geographic spread highlights the adaptability of the plant within various tropical ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Huperzia phlegmaria is characterized by its distinct growth form as a herbaceous plant. This species functions as a self-supporting organism within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Huperzia phlegmaria serves as a rich source of diverse chemical constituents, as evidenced by recent phytochemical investigations. Research conducted on aerial parts collected in Vietnam has successfully identified several key compounds within the plant. Specifically, the species contains the known compounds lycophlegmariol A and phlegmariurine B. Furthermore, chemical analysis has confirmed the presence of 5-hydroxymethyl-2-furaldehyde and loliolide within its profile. These findings contribute to a deeper understanding of the complex alkaloid and secondary metabolite makeup of this species.
Conditions
Huperzia phlegmaria serves as a promising medicinal resource for the treatment of Alzheimer's disease due to its unique bioactive alkaloids. These plant-derived compounds, specifically huperphlegmines A and B, demonstrate significant acetylcholinesterase inhibitory activities within the neural system. By inhibiting the acetylcholinesterase enzyme, these substances help address the neurodegenerative processes associated with memory loss. The presence of these alkaloids offers a potential therapeutic pathway to alleviate the symptoms of Alzheimer's disease. Consequently, the species is recognized for its pharmaceutical potential in managing this disorder through targeted enzymatic inhibition.
Preparations
Huperzia phlegmaria is prepared as aerial parts to facilitate the isolation of specific chemical compounds. These aerial parts were utilized in Vietnam to extract two novel Lycopodium alkaloids known as huperphlegmines A and B. By processing the plant in this manner, researchers were able to identify these unique alkaloids alongside several other known substances. The extraction from the aerial parts proved essential for elucidating the complex chemical structures of the isolated molecules. Ultimately, this specific preparation allowed for the testing of the plant's components for acetylcholinesterase inhibitory activities.